Alta Stays Flexible with New $500 Million Fund

Now, Alta Partners is shifting direction. Rather than raise a fourth early-stage biopharma fund, Alta opted to raise a single $500 million fund, Alta Partners VIII, which it will commit to biopharmaceutical and medical device companies of all stages.